Clinical trial

Safety and Dose Ranging Study for OWL-EVO1 as a Lung Cancer EVOC® Probe (Evolution)

NCT05510674

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2021-07-06

PhasePHASE1

Study timeline

Study start (actual)2021-07-06Date precision: day

Registry last updated2023-12-20

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Lung Cancerunresolved

Interventions

OWL-EVO1DIAGNOSTIC_TEST

Sponsors & collaborators

Owlstone Ltdlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05510674 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.